Evidence map›Paper›PMID 34787531›Full record

ArticleRenal failure2021

Relationship between selection of dosage forms of vitamin D receptor activators and short-term survival of patients on hemodialysis.

Eri Koshi-Ito, Daijo Inaguma, Shigehisa Koide, Kazuo Takahashi, Hiroki Hayashi, Naotake Tsuboi, Midori Hasegawa, Shoichi Maruyama, Yukio Yuzawa

Open access · goldAbstract readMulticenter Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Renal failure, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 79% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Eri Koshi-ItoDepartment of Nephrology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Daijo InagumaDepartment of Nephrology, Fujita Health University School of Medicine, Toyoake, Japan.ORCID 0000-0002-3977-5933
Shigehisa KoideDepartment of Nephrology, Fujita Health University School of Medicine, Toyoake, Japan.
Kazuo TakahashiDepartment of Nephrology, Fujita Health University School of Medicine, Toyoake, Japan.
Hiroki HayashiDepartment of Nephrology, Fujita Health University School of Medicine, Toyoake, Japan.
Naotake TsuboiDepartment of Nephrology, Fujita Health University School of Medicine, Toyoake, Japan.
Midori HasegawaDepartment of Nephrology, Fujita Health University School of Medicine, Toyoake, Japan.
Shoichi MaruyamaDepartment of Nephrology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Yukio YuzawaDepartment of Nephrology, Fujita Health University School of Medicine, Toyoake, Japan.
Fujita Health University · JPNagoya University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe benefits of vitamin D receptor activators (VDRAs) for patients with chronic kidney disease are well recognized. However, the optimal criteria for patient selection, dosage forms, and duration providing the highest benefit and the least potential risk remain to be confirmed. MATERIALS AND

methodsThe study population was derived from the Aichi Cohort Study of Prognosis in Patients Newly Initiated into Dialysis, a multicenter prospective cohort study of 1520 incident dialysis patients. According to the VDRA usage status in March 2015 (interim report), the 967 patients surviving after March 2015 were classified into three groups: without VDRA (NV,

resultsThere were 104 deaths (NV,

conclusionThis study demonstrated the impact of the VDRA dosage form on the short-term survival of incident hemodialysis patients during the introduction period. Our results suggest that relatively early initiation of intravenous VDRA in patients beginning hemodialysis may have some clinical potential.

Indexed as

Administration, IntravenousAdministration, OralAgedCause of DeathDose-Response Relationship, DrugDrug Administration ScheduleFemaleHumansJapanMaleMiddle AgedProspective StudiesReceptors, CalcitriolRenal DialysisRenal Insufficiency, ChronicRisk FactorsReceptors, Calcitriolchronic kidney diseasedialysismortalityVitamin Dvitamin D receptor activator

Identifiers

PMID34787531
PMCPMC8604548
OpenAlexW3212328161

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.